How has been the historical performance of Cryogenic OGS?

Cryogenic OGS has shown steady growth in net sales and profitability over the past three years, with net sales increasing from 22.02 Cr in Mar'23 to 32.90 Cr in Mar'25, and profit after tax rising from 4.08 Cr to 6.09 Cr. The company maintains a healthy balance sheet with no long-term borrowings and improved cash flow.

Answer:<BR>The historical performance of Cryogenic OGS shows a steady growth in net sales and profitability over the past three years.<BR><BR>Breakdown:<BR>Cryogenic OGS has demonstrated a consistent increase in net sales, rising from 22.02 Cr in Mar'23 to 24.25 Cr in Mar'24, and further to 32.90 Cr in Mar'25. Total operating income mirrored this trend, reaching 32.90 Cr in Mar'25. However, raw material costs also increased significantly, from 11.70 Cr in Mar'23 to 21.26 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 16.37 Cr in Mar'23 to 24.94 Cr in Mar'25, yet the operating profit (PBDIT) improved from 6.34 Cr in Mar'23 to 8.85 Cr in Mar'25. Profit before tax also saw an upward trajectory, increasing from 5.48 Cr in Mar'23 to 8.27 Cr in Mar'25, while profit after tax rose from 4.08 Cr to 6.09 Cr in the same period. The earnings per share (EPS) increased from 3.89 in Mar'23 to 5.8 in Mar'25. On the balance sheet, total assets grew from 23.95 Cr in Mar'23 to 33.73 Cr in Mar'25, with total liabilities also increasing from 23.95 Cr to 33.73 Cr. The company maintained no long-term borrowings, and cash and cash equivalents rose from 8.10 Cr in Mar'23 to 11.07 Cr in Mar'25, indicating a positive cash flow position. Overall, Cryogenic OGS has shown robust growth in sales and profitability, alongside a healthy balance sheet.

Is Cryogenic OGS overvalued or undervalued?

As of October 17, 2025, Cryogenic OGS is considered very expensive and overvalued with a PE ratio of 42.91, despite recent strong stock returns of 17.08% and 22.98% over the past week and month, respectively, making it an unfavorable investment at its current price of 183.00.

As of 17 October 2025, the valuation grade for Cryogenic OGS has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently overvalued based on its key financial ratios, including a PE ratio of 42.91, an EV to EBITDA ratio of 29.49, and a Price to Book Value of 5.23. <BR><BR>When compared to its peers, Cryogenic OGS stands out with a higher PE ratio than Thermax at 55.98 and BEML Ltd at 61.47, both of which are also classified as very expensive. The company has shown strong returns over the past week and month, outperforming the Sensex with a stock return of 17.08% and 22.98%, respectively. However, despite these short-term gains, the overall valuation suggests that Cryogenic OGS is not a favorable investment at its current price of 183.00.

Which are the latest news on Cryogenic OGS?

Why is Cryogenic OGS falling/rising?

As of 13-Dec, Cryogenic OGS Ltd's stock price is at 192.00, down 2.04% and underperforming its sector. Despite a recent weekly gain, the stock has declined 11.91% over the past month, with reduced investor participation and volatility contributing to the current downward trend.

As of 13-Dec, Cryogenic OGS Ltd's stock price is currently at 192.00, reflecting a decrease of 4.0 points or 2.04%. The stock has underperformed its sector by 3.24% today, despite opening with a gain of 3.06% and reaching an intraday high of Rs 202. However, it also touched a low of Rs 190.05 during the day, indicating significant volatility.<BR><BR>The stock's performance over the past week shows a positive return of 4.07%, contrasting with a slight decline in the benchmark Sensex, which fell by 0.52%. Nevertheless, the stock has experienced a substantial decline of 11.91% over the past month, while the Sensex has gained 0.95% in the same period. This longer-term underperformance may be contributing to the current downward pressure on the stock price.<BR><BR>Additionally, there has been a notable decrease in investor participation, with delivery volume dropping by 63.04% compared to the 5-day average, suggesting reduced interest from investors. The weighted average price indicates that more trading occurred closer to the day's low, further emphasizing the downward trend. Although the stock remains above its 5-day, 50-day, 100-day, and 200-day moving averages, it is below the 20-day moving average, which may signal a bearish sentiment among traders.<BR><BR>Overall, the combination of recent declines, reduced investor participation, and volatility in today's trading has contributed to the falling stock price of Cryogenic OGS Ltd.